Indonesia · Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.79 trillion. The enterprise value is 1.48 trillion.
| Market Cap | 1.79T |
| Enterprise Value | 1.48T |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jun 8, 2026 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 5.38.
| PE Ratio | 5.38 |
| Forward PE | n/a |
| PS Ratio | 1.33 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | 5.97 |
| P/OCF Ratio | 5.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.18, with an EV/FCF ratio of 4.94.
| EV / Earnings | 4.45 |
| EV / Sales | 1.10 |
| EV / EBITDA | 3.18 |
| EV / EBIT | 3.44 |
| EV / FCF | 4.94 |
Financial Position
The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.00 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.06 |
| Interest Coverage | 185.06 |
Financial Efficiency
Return on equity (ROE) is 37.14% and return on invested capital (ROIC) is 50.51%.
| Return on Equity (ROE) | 37.14% |
| Return on Assets (ROA) | 24.11% |
| Return on Invested Capital (ROIC) | 50.51% |
| Return on Capital Employed (ROCE) | 42.06% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | 3.77B |
| Profits Per Employee | 930.62M |
| Employee Count | 358 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, PT Merck Tbk has paid 114.67 billion in taxes.
| Income Tax | 114.67B |
| Effective Tax Rate | 25.61% |
Stock Price Statistics
The stock price has increased by +42.86% in the last 52 weeks. The beta is 0.17, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +42.86% |
| 50-Day Moving Average | 3,780.00 |
| 200-Day Moving Average | 3,431.85 |
| Relative Strength Index (RSI) | 60.31 |
| Average Volume (20 Days) | 58,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.35 trillion and earned 333.16 billion in profits. Earnings per share was 743.66.
| Revenue | 1.35T |
| Gross Profit | 674.82B |
| Operating Income | 431.14B |
| Pretax Income | 447.83B |
| Net Income | 333.16B |
| EBITDA | 457.11B |
| EBIT | 431.14B |
| Earnings Per Share (EPS) | 743.66 |
Balance Sheet
The company has 328.00 billion in cash and 17.46 billion in debt, with a net cash position of 310.54 billion or 693.17 per share.
| Cash & Cash Equivalents | 328.00B |
| Total Debt | 17.46B |
| Net Cash | 310.54B |
| Net Cash Per Share | 693.17 |
| Equity (Book Value) | 964.29B |
| Book Value Per Share | 2,152.43 |
| Working Capital | 809.59B |
Cash Flow
In the last 12 months, operating cash flow was 311.05 billion and capital expenditures -10.87 billion, giving a free cash flow of 300.18 billion.
| Operating Cash Flow | 311.05B |
| Capital Expenditures | -10.87B |
| Depreciation & Amortization | 25.98B |
| Net Borrowing | -9.95B |
| Free Cash Flow | 300.18B |
| FCF Per Share | 670.04 |
Margins
Gross margin is 49.96%, with operating and profit margins of 31.92% and 24.67%.
| Gross Margin | 49.96% |
| Operating Margin | 31.92% |
| Pretax Margin | 33.15% |
| Profit Margin | 24.67% |
| EBITDA Margin | 33.84% |
| EBIT Margin | 31.92% |
| FCF Margin | 22.22% |
Dividends & Yields
This stock pays an annual dividend of 275.00, which amounts to a dividend yield of 6.89%.
| Dividend Per Share | 275.00 |
| Dividend Yield | 6.89% |
| Dividend Growth (YoY) | 61.76% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 59.61% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.89% |
| Earnings Yield | 18.59% |
| FCF Yield | 16.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
PT Merck Tbk has an Altman Z-Score of 7.38 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.38 |
| Piotroski F-Score | 5 |